Thomas Englese
Chief Commercial Officer, ELUTIA INC.
Companies
- Tonix PharmaceuticalsChief Commercial Officer Sep 8, 2026 to now1
- ELUTIA INC.Chief Commercial Officer Oct 7, 2020 to Mar 9, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- ELUTIA INC. ELUT17,917 shares3$14.2K at $0.79Mar 9, 2023
Tonix Pharmaceuticals TNXP694 shares4$4.5K at $6.46Sep 8, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 9, 2023Sold 289 shares at $4.30 of ELUTIA INC.3
- Mar 8, 2023Exercised options 937 shares of ELUTIA INC.3
- Sep 8, 2022Shares withheld for tax 4,728 shares at $7.30 of ELUTIA INC.5
- Sep 8, 2022Exercised options 15,390 shares of ELUTIA INC.5
- Mar 10, 2022Sold 276 shares of ELUTIA INC.6
- Mar 8, 2022Exercised options 938 shares of ELUTIA INC.6
- Dec 14, 2021Bought 4,580 shares at $6.10 of ELUTIA INC.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Sep 12, 2022
- 6SEC EDGARForm 4 filed Mar 10, 2022
- 7SEC EDGARForm 4 filed Dec 15, 2021